Clinical Trials Browser

Phase 2 × Solutions × 90 days × Clear all

NCT05952804 2026-04-21

IVIG for Infection Prevention After CAR-T-Cell Therapy

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms